Scot Garg

Impact of periprocedural major adverse events on 10-year mortality after revascularisation

Kotoku N, Serruys P, Ninomiya K, Soo A, Masuda S, Kageyama S, Revaiah P, Mack M, Holmes DR, Morice M, Davierwala P, Mohr F, Milojevic M, Kappetein A, Garg S, Onuma Y

March 20, 2023 | 10.4244/EIJ-D-22-00681

Rocky II, Rambo II, and the ACURATE neo2

Serruys P, Elkoumy A, Garg S

January 23, 2023 | 10.4244/EIJ-E-22-00050

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter RJ, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits P, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys P

August 19, 2022 | 10.4244/EIJ-D-21-00766

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial

Ono M, Hara H, Kawashima H, Gao C, Wang R, Wykrzykowska JJ, Piek J, Garg S, Hamm C, Steg PG, Valgimigli M, Windecker S, Vranckx P, Onuma Y, Serruys P

August 5, 2022 | 10.4244/EIJ-D-21-00870

Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations

Lunardi M, Louvard Y, Lefèvre T, Stankovic G, Burzotta F, Kassab G, Lassen J, Darremont O, Garg S, Koo B, Holm N, Johnson T, Pan M, Chatzizisis Y, Banning A, Chieffo A, Dudek D, Hildick-Smith D, Garot J, Henry T, Dangas G, Stone G, Krucoff M, Cutlip D, Mehran R, Wijns W, Sharif F, Serruys P, Onuma Y

May 18, 2022 | 10.4244/EIJ-E-22-00018

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

October 23, 2020 | 10.4244/EIJ-D-19-00498

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg PG, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek J, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Interventional cardiology: review of the year 2017

Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, Katagiri Y, Soliman O, Garg S, Onuma Y, Serruys P

April 20, 2018 | 10.4244/EIJ-D-18-00066

How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis?

Ormerod J, Lim J, Chandrasekaran B, Ramcharitar S, Garg S, Singh R, McDonald J, Balachandran K, Wykrzykowska JJ

January 20, 2016 | 10.4244/EIJV11I9A217

The FIREHAWK® stent: will it achieve its potential?

Garg S

May 21, 2013 | 10.4244/EIJV9I1A2

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P

November 30, 2011 | 10.4244/EIJV7I7A134

How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?

Gutiérrez-Chico J-L, Garcia-Garcia H, Ligthart J, Bol-Raap G, Garg S, Bekkers J, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A102

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A97

Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease

Gutiérrez-Chico J-L, Regar E, van Geuns R, Garg S, Schultz C, Van Mieghem N, Duckers H, Serruys P

June 30, 2011 | 10.4244/EIJV7I2A44

Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study

Garg S, Sarno G, Gutiérrez-Chico J-L, Garcia-Garcia H, Gomez-Lara J, Serruys P

April 20, 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P

April 20, 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

Garg S, Wykrzykowska JJ, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

March 21, 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska JJ, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P

March 21, 2011

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

Legrand V, Garg S, Serruys P, Virtanen K, Szurawitzki G, Voudris V, Fontanelli A, Endersen K, Kranjec I, Rademaker T, Stefanadis C, Wittebols K

February 21, 2011

Scot Garg

Latest news